1. Home
  2. DCO vs TPST Comparison

DCO vs TPST Comparison

Compare DCO & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$122.45

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$2.45

Market Cap

11.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
TPST
Founded
1849
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
11.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DCO
TPST
Price
$122.45
$2.45
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$128.40
$10.00
AVG Volume (30 Days)
157.6K
90.9K
Earning Date
02-26-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$806,224,000.00
N/A
Revenue This Year
$6.12
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.17
N/A
52 Week Low
$51.76
$2.16
52 Week High
$124.50
$12.37

Technical Indicators

Market Signals
Indicator
DCO
TPST
Relative Strength Index (RSI) 67.97 35.01
Support Level $119.84 $2.16
Resistance Level $124.50 $2.46
Average True Range (ATR) 4.12 0.22
MACD -0.16 0.01
Stochastic Oscillator 77.02 11.90

Price Performance

Historical Comparison
DCO
TPST

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: